This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malumbres, M.
Right arrow Articles by Pellicer, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malumbres, M.
Right arrow Articles by Pellicer, A.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 2000, p. 2915-2925, Vol. 20, No. 8
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Cellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b

Marcos Malumbres,dagger Ignacio Pérez De Castro, María I. Hernández, María Jiménez, Teresa Corral, and Angel Pellicer*

Department of Pathology and Kaplan Comprehensive Cancer Center, New York University Medical Center, New York, New York 10016

Received 26 July 1999/Returned for modification 13 September 1999/Accepted 27 January 2000

The cell cycle inhibitor p15INK4b is frequently inactivated by homozygous deletion together with p16INK4a and p19ARF in some types of tumors. Although the tumor suppressor capability of p15INK4b is still questioned, it has been found to be specifically inactivated by hypermethylation in hematopoietic malignancies in the absence of p16INK4a alterations. Here we show that, in vitro, p15INK4b is a strong inhibitor of cellular transformation by Ras. Surprisingly, p15INK4b is induced in cultured cells by oncogenic Ras to an extent similar to that of p16INK4a, and their expression is associated with premature G1 arrest and senescence. Ras-dependent induction of these two INK4 genes is mediated mainly by the Raf-Mek-Erk pathway. Studies with activated and dominant negative forms of Ras effectors indicate that the Raf-Mek-Erk pathway is essential for induction of both the p15INK4b and p16INK4a promoters, although other Ras effector pathways can collaborate, giving rise to a stronger response. Our results indicate that p15INK4b, by itself, is able to stop cell transformation by Ras and other oncogenes such as Rgr (a new oncogene member of the Ral-GDS family, whose action is mediated through Ras). In fact, embryonic fibroblasts isolated from p15INK4b knockout mice are susceptible to transformation by the Ras or Rgr oncogene whereas wild-type embryonic fibroblasts are not. Similarly, p15INK4b-deficient mouse embryo fibroblasts are more sensitive than wild-type cells to transformation by a combination of the Rgr and E1A oncogenes. The cell cycle inhibitor p15INK4b is therefore involved, at least in some cell types, in the tumor suppressor activity triggered after inappropriate oncogenic Ras activation in the cell.

* Corresponding author. Mailing address: Department of Pathology and Kaplan Comprehensive Cancer Center, New York University Medical Center, 550 First Ave., New York, NY 10016. Phone: (212) 263-5342. Fax: (212) 263-8211. E-mail: pellia01{at}mcrcr.med.nyu.edu.

dagger Present address: Centro Nacional de Investigaciones Oncológicas Carlos III, Crta. Majadahonda-Pozuelo, 28220 Majadahonda, Madrid, Spain.

Molecular and Cellular Biology, April 2000, p. 2915-2925, Vol. 20, No. 8
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Watanabe, T., Tsuda, M., Tanaka, S., Ohba, Y., Kawaguchi, H., Majima, T., Sawa, H., Minami, A. (2009). Adaptor Protein Crk Induces Src-Dependent Activation of p38 MAPK in Regulation of Synovial Sarcoma Cell Proliferation. Mol Cancer Res 7: 1582-1592 [Abstract] [Full Text]  
  • Huang, B., Deo, D., Xia, M., Vassilev, L. T. (2009). Pharmacologic p53 Activation Blocks Cell Cycle Progression but Fails to Induce Senescence in Epithelial Cancer Cells. Mol Cancer Res 7: 1497-1509 [Abstract] [Full Text]  
  • Bodempudi, V., Yamoutpoor, F., Pan, W., Dudek, A. Z., Esfandyari, T., Piedra, M., Babovick-Vuksanovic, D., Woo, R. A., Mautner, V. F., Kluwe, L., Clapp, D. W., De Vries, G. H., Thomas, S. L., Kurtz, A., Parada, L. F., Farassati, F. (2009). Ral Overactivation in Malignant Peripheral Nerve Sheath Tumors. Mol. Cell. Biol. 29: 3964-3974 [Abstract] [Full Text]  
  • Kim, D.-I., Lee, S.-J., Lee, S.-B., Park, K., Kim, W.-J., Moon, S.-K. (2008). Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression. Carcinogenesis 29: 1701-1709 [Abstract] [Full Text]  
  • Callejas-Valera, J. L., Guinea-Viniegra, J., Ramirez-Castillejo, C., Recio, J. A., Galan-Moya, E., Martinez, N., Rojas, J. M., Cajal, S. R. y, Sanchez-Prieto, R. (2008). E1a Gene Expression Blocks the ERK1/2 Signaling Pathway by Promoting Nuclear Localization and MKP Up-regulation: IMPLICATION IN v-H-Ras-INDUCED SENESCENCE. J. Biol. Chem. 283: 13450-13458 [Abstract] [Full Text]  
  • Xu, M., Yu, Q., Subrahmanyam, R., Difilippantonio, M. J., Ried, T., Sen, J. M. (2008). {beta}-Catenin Expression Results in p53-Independent DNA Damage and Oncogene-Induced Senescence in Prelymphomagenic Thymocytes In Vivo. Mol. Cell. Biol. 28: 1713-1723 [Abstract] [Full Text]  
  • Mallette, F. A., Gaumont-Leclerc, M.-F., Huot, G., Ferbeyre, G. (2007). Myc Down-regulation as a Mechanism to Activate the Rb Pathway in STAT5A-induced Senescence. J. Biol. Chem. 282: 34938-34944 [Abstract] [Full Text]  
  • Ruiz-Llorente, S., Montero-Conde, C., Milne, R. L., Moya, C. M., Cebrian, A., Leton, R., Cascon, A., Mercadillo, F., Landa, I., Borrego, S., de Nanclares, G. P., Alvarez-Escola, C., Diaz-Perez, J. A., Carracedo, A., Urioste, M., Gonzalez-Neira, A., Benitez, J., Santisteban, P., Dopazo, J., Ponder, B. A., Robledo, M., the Medullary Thyroid Carcinoma Clinical Group, (2007). Association Study of 69 Genes in the Ret Pathway Identifies Low-penetrance Loci in Sporadic Medullary Thyroid Carcinoma. Cancer Res. 67: 9561-9567 [Abstract] [Full Text]  
  • Koyama, M., Matsuzaki, Y., Yogosawa, S., Hitomi, T., Kawanaka, M., Sakai, T. (2007). ZD1839 induces p15INK4b and causes G1 arrest by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway. Molecular Cancer Therapeutics 6: 1579-1587 [Abstract] [Full Text]  
  • Houle, C. D., Ton, T.-V. T., Clayton, N., Huff, J., Hong, H.-H. L., Sills, R. C. (2006). Frequent p53 and H-ras Mutations in Benzene- and Ethylene Oxide-Induced Mammary Gland Carcinomas from B6C3F1 Mice. Toxicol Pathol 34: 752-762 [Abstract] [Full Text]  
  • Wu, W.-S., Tsai, R. K., Chang, C. H., Wang, S., Wu, J.-R., Chang, Y.-X. (2006). Reactive Oxygen Species Mediated Sustained Activation of Protein Kinase C {alpha} and Extracellular Signal-Regulated Kinase for Migration of Human Hepatoma Cell Hepg2. Mol Cancer Res 4: 747-758 [Abstract] [Full Text]  
  • Kortum, R. L., Johnson, H. J., Costanzo, D. L., Volle, D. J., Razidlo, G. L., Fusello, A. M., Shaw, A. S., Lewis, R. E. (2006). The Molecular Scaffold Kinase Suppressor of Ras 1 Is a Modifier of RasV12-Induced and Replicative Senescence.. Mol. Cell. Biol. 26: 2202-2214 [Abstract] [Full Text]  
  • Perez de Castro, I., Benet, M., Jimenez, M., Alzabin, S., Malumbres, M., Pellicer, A. (2005). Mouse p10, an Alternative Spliced Form of p15INK4b, Inhibits Cell Cycle Progression and Malignant Transformation. Cancer Res. 65: 3249-3256 [Abstract] [Full Text]  
  • Kim, E.-J., Park, J.-I., Nelkin, B. D. (2005). IFI16 Is an Essential Mediator of Growth Inhibition, but Not Differentiation, Induced by the Leukemia Inhibitory Factor/JAK/STAT Pathway in Medullary Thyroid Carcinoma Cells. J. Biol. Chem. 280: 4913-4920 [Abstract] [Full Text]  
  • Passioura, T., Dolnikov, A., Shen, S., Symonds, G. (2005). N-Ras-Induced Growth Suppression of Myeloid Cells Is Mediated by IRF-1. Cancer Res. 65: 797-804 [Abstract] [Full Text]  
  • Vaque, J. P., Navascues, J., Shiio, Y., Laiho, M., Ajenjo, N., Mauleon, I., Matallanas, D., Crespo, P., Leon, J. (2005). Myc Antagonizes Ras-mediated Growth Arrest in Leukemia Cells through the Inhibition of the Ras-ERK-p21Cip1 Pathway. J. Biol. Chem. 280: 1112-1122 [Abstract] [Full Text]  
  • Goeman, F., Thormeyer, D., Abad, M., Serrano, M., Schmidt, O., Palmero, I., Baniahmad, A. (2005). Growth Inhibition by the Tumor Suppressor p33ING1 in Immortalized and Primary Cells: Involvement of Two Silencing Domains and Effect of Ras. Mol. Cell. Biol. 25: 422-431 [Abstract] [Full Text]  
  • Jimenez, M., de Castro, I. P., Benet, M., Garcia, J. F., Inghirami, G., Pellicer, A. (2004). The Rgr Oncogene Induces Tumorigenesis in Transgenic Mice. Cancer Res. 64: 6041-6049 [Abstract] [Full Text]  
  • Schmidt, M., Bies, J., Tamura, T., Ozato, K., Wolff, L. (2004). The interferon regulatory factor ICSBP/IRF-8 in combination with PU.1 up-regulates expression of tumor suppressor p15Ink4b in murine myeloid cells. Blood 103: 4142-4149 [Abstract] [Full Text]  
  • Kranc, K. R., Bamforth, S. D., Braganca, J., Norbury, C., van Lohuizen, M., Bhattacharya, S. (2003). Transcriptional Coactivator Cited2 Induces Bmi1 and Mel18 and Controls Fibroblast Proliferation via Ink4a/ARF. Mol. Cell. Biol. 23: 7658-7666 [Abstract] [Full Text]  
  • Lahlou, H., Saint-Laurent, N., Esteve, J.-P., Eychene, A., Pradayrol, L., Pyronnet, S., Susini, C. (2003). sst2 Somatostatin Receptor Inhibits Cell Proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 Activation. J. Biol. Chem. 278: 39356-39371 [Abstract] [Full Text]  
  • Ohtani, N., Brennan, P., Gaubatz, S., Sanij, E., Hertzog, P., Wolvetang, E., Ghysdael, J., Rowe, M., Hara, E. (2003). Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5. JCB 162: 173-183 [Abstract] [Full Text]  
  • Roninson, I. B. (2003). Tumor Cell Senescence in Cancer Treatment. Cancer Res. 63: 2705-2715 [Abstract] [Full Text]  
  • Park, J.-I., Strock, C. J., Ball, D. W., Nelkin, B. D. (2003). The Ras/Raf/MEK/Extracellular Signal-Regulated Kinase Pathway Induces Autocrine-Paracrine Growth Inhibition via the Leukemia Inhibitory Factor/JAK/STAT Pathway. Mol. Cell. Biol. 23: 543-554 [Abstract] [Full Text]  
  • Zou, X., Ray, D., Aziyu, A., Christov, K., Boiko, A. D., Gudkov, A. V., Kiyokawa, H. (2002). Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence. Genes Dev. 16: 2923-2934 [Abstract] [Full Text]  
  • Marcotte, R., Wang, E. (2002). Replicative Senescence Revisited. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 57: B257-269 [Abstract] [Full Text]  
  • Lubomierski, N., Kersting, M., Bert, T., Muench, K., Wulbrand, U., Schuermann, M., Bartsch, D., Simon, B. (2001). Tumor Suppressor Genes in the 9p21 Gene Cluster Are Selective Targets of Inactivation in Neuroendocrine Gastroenteropancreatic Tumors. Cancer Res. 61: 5905-5910 [Abstract] [Full Text]  
  • Lin, A. W., Lowe, S. W. (2001). Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation. Proc. Natl. Acad. Sci. USA 10.1073/pnas.091100298v1 [Abstract] [Full Text]  
  • Ferbeyre, G., de Stanchina, E., Querido, E., Baptiste, N., Prives, C., Lowe, S. W. (2000). PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14: 2015-2027 [Abstract] [Full Text]  
  • Lin, A. W., Lowe, S. W. (2001). Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation. Proc. Natl. Acad. Sci. USA 98: 5025-5030 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»